Shares outstanding · 2011–2025
Niagen Bioscience shares outstanding
79.7M+3.1% · FY2025
Niagen Bioscience (NAGE) reported 79.7M in shares outstanding for fiscal 2025, +3.1% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 79.7M | +3.1% | Open → |
| FY20242024-12-31 | 77.3M | +3.1% | Open → |
| FY20232023-12-31 | 75.0M | +0.6% | Open → |
| FY20222022-12-31 | 74.6M | +9.5% | Open → |
| FY20212021-12-31 | 68.1M | +10.1% | Open → |
| FY20202020-12-31 | 61.9M | +3.9% | Open → |
| FY20192019-12-31 | 59.6M | +108,019.6% | Open → |
| FY20182018-12-31 | 55,089 | −99.9% | Open → |
| FY20172017-12-30 | 54.7M | +45.7% | Open → |
| FY20162016-12-31 | 37.5M | +4.3% | Open → |
| FY20152016-01-02 | 36.0M | −65.8% | Open → |
| FY20142015-01-03 | 105M | +0.4% | Open → |
| FY20132013-11-20 | 105M | +13.8% | Open → |
| FY20122012-12-29 | 92.1M | +26.3% | Open → |
| FY20112011-12-31 | 72.9M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +0.6%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience shares outstanding |url=https://companiesranked.com/en/company/niagen-bioscience/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/shares-outstandingBibTeX
@misc{companiesranked-en-company-niagen-bioscience-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001386570-26-000043 · August 4, 2026
{{cite web |title=Niagen Bioscience shares outstanding — 10-Q (0001386570-26-000043) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000043/cdcx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.